Ambien vs. Quviviq
See how Ambien and Quviviq compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Ambien is a GABA-A sedative approved only for trouble falling asleep, while Quviviq is a dual orexin blocker approved for falling asleep, staying asleep, or both.
Ambien is available as a low-cost generic, while Quviviq has no generic and costs substantially more per month.
Both are Schedule IV controlled substances with warnings for complex sleep behaviors like sleepwalking or sleep-driving.
Ambien vs. Quviviq Drug Summary
Ambien
Ambien (zolpidem) is a non-benzodiazepine sedative-hypnotic that works on GABA-A receptors in the brain. It's FDA-approved for short-term treatment of insomnia in people who have trouble falling asleep. It comes as an immediate-release tablet taken once nightly on an empty stomach.
Quviviq
Quviviq (daridorexant) is a dual orexin receptor antagonist that blocks the brain's wake-promoting orexin signals rather than boosting GABA. It's FDA-approved for insomnia in adults who have trouble falling asleep, staying asleep, or both. It's taken as an oral tablet once nightly.
Ambien vs. Quviviq Side Effects
Ambien
Quviviq
Ambien vs. Quviviq Dosage
Ambien
Quviviq
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 10 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 25 mg once nightly | At the start |
| Maximum dose | 50 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Ambien
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 10 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Quviviq
| STAGE | DOSE | WHEN |
| Starting dose | 25 mg once nightly | At the start |
| Maximum dose | 50 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Ambien vs. Quviviq Indications
Ambien
Ambien is approved only for short-term insomnia treatment, specifically to help people fall asleep faster. It is not approved for insomnia where the main issue is staying asleep, and it isn't meant for long-term nightly use.
Helps you fall asleep faster
Approved for short-term use only
Not approved for children
Available as a low-cost generic
Quviviq
Quviviq is approved for adults with insomnia involving trouble falling asleep, staying asleep, or both. Unlike Ambien, its labeling addresses sleep maintenance as well as sleep onset, and it isn't restricted to short-term use.
Helps with falling and staying asleep
No short-term use restriction in labeling
Not approved for narcolepsy
Approved for adults only
Ambien vs. Quviviq Pros and Cons
Ambien
Ambien has decades of real-world use and is available as an inexpensive generic, but it only targets sleep onset, not staying asleep. It carries a higher labeled rate of dizziness and next-day drowsiness than Quviviq.
Pros
Inexpensive generic, roughly $15 to $90 a month
Fast onset when taken on an empty stomach
Decades of real-world clinical use
Dosing tailored by sex (5 mg or 10 mg)
Cons
Higher labeled rates of dizziness and drowsiness
Not approved for staying asleep
Prominent complex sleep behavior warnings
Not approved for long-term nightly use
Quviviq
Quviviq covers both falling asleep and staying asleep, with lower labeled rates of dizziness and morning grogginess than Ambien. It's newer to market and, without a generic, costs far more out of pocket each month.
Pros
Approved for both falling and staying asleep
Lower labeled rates of dizziness and drowsiness
No withdrawal symptoms seen in clinical trials
Newer mechanism that blocks orexin, not GABA
Cons
No generic; roughly $520 to $685 a month
Contraindicated in narcolepsy
Less long-term real-world data than Ambien
Dose reduction needed with liver impairment
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.